PICK A TIME SLOT
₹ Price not available
Yelahanka - Bengaluru
₹
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. G. Rama Mohan Reddy is a highly accomplished Nuclear Medicine specialist with over 15 years of experience in advanced molecular imaging and targeted radionuclide therapy. Trained at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, he has been extensively involved in high-volume oncologic imaging, thyroid oncology, theranostics, and PET-CT diagnostics across leading tertiary cancer centres.
His expertise spans comprehensive PET-CT imaging for oncology, neurology, cardiology, and endocrine disorders, along with advanced radionuclide therapies for thyroid cancer, neuroendocrine tumors, prostate cancer, and bone metastases. With hands-on experience of over 50,000 PET-CT scans and extensive exposure to cutting-edge GE and Siemens systems, Dr. Reddy has played a key role in integrating molecular imaging into multidisciplinary cancer management.
He is also deeply engaged in academic research, contributing to multiple indexed international publications and abstracts, thereby advancing evidence-based nuclear medicine practice in India.
- PET-CT Imaging (FDG, PSMA, DOTANOC, DOPA, NaF)
- Thyroid Cancer & Hyperthyroidism Management (131I Therapy)
- Theranostics (177Lu Therapy for NET & Prostate Cancer)
- Nuclear Cardiology & Myocardial Perfusion Imaging
- Radiosynovectomy for Chronic Arthritis
- Bone Pain Palliation Using 153Samarium & 89Strontium
- English
- Kannada
- Telugu
- Hindi
- Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R.18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population. Nucl Med Commun. 2012 Sep;33(9):960-6.
- Shamim SA, Kumar R, Halanaik D, Shandal V, Reddy RM, Bal CS, Malhotra A. Detection of recurrent disease in colorectal cancer. Nucl Med Commun 2010 Jun; 31(6);590-6.
- Santra A, Kumar R, Reddy R, Halanaik D, Kumar R, Bal CS, Malhotra A.FDG PET –CT in the management of primary breast lymphoma, Clin Nucl Med. 2009 Dec;34(12):848-53.
- Sharma P, Kumar R, Singh H, Jeph S, Patnecha M, Reddy RM, Naswa N, Bal C, Malhotra A. Imaging thrombus in cancer patients with FDG PET-CT. Jpn J Radiol. 2012 Feb;30(2):95-104. Epub 2011 Dec 22.
- Sharma P, Dhull VS, Reddy RM, Bal C, Thulkar S, Malhotra A, Kumar R. Hybrid SPECT-CT for characterizing isolated vertebral lesions observed by bone scintigraphy: comparison with planar scintigraphy, SPECT, and CT. Diagn Interv Radiol. 2012 Aug 3. doi: 10.4261/1305-3825.DIR.5790-12.1. [Epub ahead of print]
- Sharma JB, Karmakar D, Kumar R, Shamim SA, Kumar S, Singh N, Roy KK, Reddy RM Comparison of PET/CT with other imaging modalities in women with genital tuberculosis. Int J Gynaecol Obstet. 2012 Aug;118(2):123-8. Epub 2012 May 30
- Sharma P, Dhull VS, Jeph S, Reddy RM, Singh H, Naswa N, Bal C, Kumar R. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG? Comparison with planar scintigraphy and SPECT in pheochromocytoma. Clin Nucl Med. (In Press).
- Naswa N, Sharma P, Gupta SK, Karunanithi S, Reddy RM, Patnecha M, Lata S, Kumar R, Malhotra A, Bal C. Dual tracer functional imaging of Gastroenteropancreatic Neuroendocrine tumors using 18F-FDG PET-CT and 68Ga-DOTANOC PET-CT: Competitive or Complimentary? Clin Nucl Med. (In Press).
- Damle N, Bal C, Reddy R, Kumar P, Vireka D. Short term outcome of empirical low fixed dose radioiodine therapy in diffuse toxic goiter. Hormones- International Journal of Endocrinology and Metabolism. (In Press)
- Chawla M, Reddy R, Kumar R, Das CJ, Agarwala S, Tiwari AM, Malhotra A, Kumar R. Role of FDG PET?CT in detection of meningeal metastasis in neuroblastoma. Pediatr Surg Int.2009 Feb;25(2):211-5
- Singh H, Sharma P, Suman K C S, Reddy RM, Bal C, Malhotra A, Kumar R. Postorchiectomy intrascrotal hematoma mimicking local recurrence on 18F-FDG PET/CT: a diagnostic dilemma. Clin Nucl Med. 2012 May;37(5):e102-3.
- Singh H, Sharma P, Reddy RM, Bal C, Malhotra A, Kumar R. Sister Mary Joseph's Nodule in endometrial carcinoma: Detection with FDG PET-CT. Clin Nucl Med (In Press)
- Singla S, Gupta S, Reddy RM, Durgapal P, Bal CS.68Ga-DOTA-NOC PET and Peptide Receptor Radionuclide Therapy in Management of Bilateral Ovarian Metastases from Gastrointestinal Carcinoid.Jpn J Clin Oncol. 2012 Oct 28. [Epub ahead of print]
Overview
Field of Expertise
Languages Spoken
Talks & Publications
- English
- Kannada
- Telugu
- Hindi
Dr. G. Rama Mohan Reddy is a highly accomplished Nuclear Medicine specialist with over 15 years of experience in advanced molecular imaging and targeted radionuclide therapy. Trained at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, he has been extensively involved in high-volume oncologic imaging, thyroid oncology, theranostics, and PET-CT diagnostics across leading tertiary cancer centres.
His expertise spans comprehensive PET-CT imaging for oncology, neurology, cardiology, and endocrine disorders, along with advanced radionuclide therapies for thyroid cancer, neuroendocrine tumors, prostate cancer, and bone metastases. With hands-on experience of over 50,000 PET-CT scans and extensive exposure to cutting-edge GE and Siemens systems, Dr. Reddy has played a key role in integrating molecular imaging into multidisciplinary cancer management.
He is also deeply engaged in academic research, contributing to multiple indexed international publications and abstracts, thereby advancing evidence-based nuclear medicine practice in India.
- PET-CT Imaging (FDG, PSMA, DOTANOC, DOPA, NaF)
- Thyroid Cancer & Hyperthyroidism Management (131I Therapy)
- Theranostics (177Lu Therapy for NET & Prostate Cancer)
- Nuclear Cardiology & Myocardial Perfusion Imaging
- Radiosynovectomy for Chronic Arthritis
- Bone Pain Palliation Using 153Samarium & 89Strontium
- Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R.18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population. Nucl Med Commun. 2012 Sep;33(9):960-6.
- Shamim SA, Kumar R, Halanaik D, Shandal V, Reddy RM, Bal CS, Malhotra A. Detection of recurrent disease in colorectal cancer. Nucl Med Commun 2010 Jun; 31(6);590-6.
- Santra A, Kumar R, Reddy R, Halanaik D, Kumar R, Bal CS, Malhotra A.FDG PET –CT in the management of primary breast lymphoma, Clin Nucl Med. 2009 Dec;34(12):848-53.
- Sharma P, Kumar R, Singh H, Jeph S, Patnecha M, Reddy RM, Naswa N, Bal C, Malhotra A. Imaging thrombus in cancer patients with FDG PET-CT. Jpn J Radiol. 2012 Feb;30(2):95-104. Epub 2011 Dec 22.
- Sharma P, Dhull VS, Reddy RM, Bal C, Thulkar S, Malhotra A, Kumar R. Hybrid SPECT-CT for characterizing isolated vertebral lesions observed by bone scintigraphy: comparison with planar scintigraphy, SPECT, and CT. Diagn Interv Radiol. 2012 Aug 3. doi: 10.4261/1305-3825.DIR.5790-12.1. [Epub ahead of print]
- Sharma JB, Karmakar D, Kumar R, Shamim SA, Kumar S, Singh N, Roy KK, Reddy RM Comparison of PET/CT with other imaging modalities in women with genital tuberculosis. Int J Gynaecol Obstet. 2012 Aug;118(2):123-8. Epub 2012 May 30
- Sharma P, Dhull VS, Jeph S, Reddy RM, Singh H, Naswa N, Bal C, Kumar R. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG? Comparison with planar scintigraphy and SPECT in pheochromocytoma. Clin Nucl Med. (In Press).
- Naswa N, Sharma P, Gupta SK, Karunanithi S, Reddy RM, Patnecha M, Lata S, Kumar R, Malhotra A, Bal C. Dual tracer functional imaging of Gastroenteropancreatic Neuroendocrine tumors using 18F-FDG PET-CT and 68Ga-DOTANOC PET-CT: Competitive or Complimentary? Clin Nucl Med. (In Press).
- Damle N, Bal C, Reddy R, Kumar P, Vireka D. Short term outcome of empirical low fixed dose radioiodine therapy in diffuse toxic goiter. Hormones- International Journal of Endocrinology and Metabolism. (In Press)
- Chawla M, Reddy R, Kumar R, Das CJ, Agarwala S, Tiwari AM, Malhotra A, Kumar R. Role of FDG PET?CT in detection of meningeal metastasis in neuroblastoma. Pediatr Surg Int.2009 Feb;25(2):211-5
- Singh H, Sharma P, Suman K C S, Reddy RM, Bal C, Malhotra A, Kumar R. Postorchiectomy intrascrotal hematoma mimicking local recurrence on 18F-FDG PET/CT: a diagnostic dilemma. Clin Nucl Med. 2012 May;37(5):e102-3.
- Singh H, Sharma P, Reddy RM, Bal C, Malhotra A, Kumar R. Sister Mary Joseph's Nodule in endometrial carcinoma: Detection with FDG PET-CT. Clin Nucl Med (In Press)
- Singla S, Gupta S, Reddy RM, Durgapal P, Bal CS.68Ga-DOTA-NOC PET and Peptide Receptor Radionuclide Therapy in Management of Bilateral Ovarian Metastases from Gastrointestinal Carcinoid.Jpn J Clin Oncol. 2012 Oct 28. [Epub ahead of print]
Languages Spoken
Overview
Field of Expertise
Talks & Publications
- PET-CT Imaging (FDG, PSMA, DOTANOC, DOPA, NaF)
- Thyroid Cancer & Hyperthyroidism Management (131I Therapy)
- Theranostics (177Lu Therapy for NET & Prostate Cancer)
- Nuclear Cardiology & Myocardial Perfusion Imaging
- Radiosynovectomy for Chronic Arthritis
- Bone Pain Palliation Using 153Samarium & 89Strontium
- English
- Kannada
- Telugu
- Hindi
- Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R.18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population. Nucl Med Commun. 2012 Sep;33(9):960-6.
- Shamim SA, Kumar R, Halanaik D, Shandal V, Reddy RM, Bal CS, Malhotra A. Detection of recurrent disease in colorectal cancer. Nucl Med Commun 2010 Jun; 31(6);590-6.
- Santra A, Kumar R, Reddy R, Halanaik D, Kumar R, Bal CS, Malhotra A.FDG PET –CT in the management of primary breast lymphoma, Clin Nucl Med. 2009 Dec;34(12):848-53.
- Sharma P, Kumar R, Singh H, Jeph S, Patnecha M, Reddy RM, Naswa N, Bal C, Malhotra A. Imaging thrombus in cancer patients with FDG PET-CT. Jpn J Radiol. 2012 Feb;30(2):95-104. Epub 2011 Dec 22.
- Sharma P, Dhull VS, Reddy RM, Bal C, Thulkar S, Malhotra A, Kumar R. Hybrid SPECT-CT for characterizing isolated vertebral lesions observed by bone scintigraphy: comparison with planar scintigraphy, SPECT, and CT. Diagn Interv Radiol. 2012 Aug 3. doi: 10.4261/1305-3825.DIR.5790-12.1. [Epub ahead of print]
- Sharma JB, Karmakar D, Kumar R, Shamim SA, Kumar S, Singh N, Roy KK, Reddy RM Comparison of PET/CT with other imaging modalities in women with genital tuberculosis. Int J Gynaecol Obstet. 2012 Aug;118(2):123-8. Epub 2012 May 30
- Sharma P, Dhull VS, Jeph S, Reddy RM, Singh H, Naswa N, Bal C, Kumar R. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG? Comparison with planar scintigraphy and SPECT in pheochromocytoma. Clin Nucl Med. (In Press).
- Naswa N, Sharma P, Gupta SK, Karunanithi S, Reddy RM, Patnecha M, Lata S, Kumar R, Malhotra A, Bal C. Dual tracer functional imaging of Gastroenteropancreatic Neuroendocrine tumors using 18F-FDG PET-CT and 68Ga-DOTANOC PET-CT: Competitive or Complimentary? Clin Nucl Med. (In Press).
- Damle N, Bal C, Reddy R, Kumar P, Vireka D. Short term outcome of empirical low fixed dose radioiodine therapy in diffuse toxic goiter. Hormones- International Journal of Endocrinology and Metabolism. (In Press)
- Chawla M, Reddy R, Kumar R, Das CJ, Agarwala S, Tiwari AM, Malhotra A, Kumar R. Role of FDG PET?CT in detection of meningeal metastasis in neuroblastoma. Pediatr Surg Int.2009 Feb;25(2):211-5
- Singh H, Sharma P, Suman K C S, Reddy RM, Bal C, Malhotra A, Kumar R. Postorchiectomy intrascrotal hematoma mimicking local recurrence on 18F-FDG PET/CT: a diagnostic dilemma. Clin Nucl Med. 2012 May;37(5):e102-3.
- Singh H, Sharma P, Reddy RM, Bal C, Malhotra A, Kumar R. Sister Mary Joseph's Nodule in endometrial carcinoma: Detection with FDG PET-CT. Clin Nucl Med (In Press)
- Singla S, Gupta S, Reddy RM, Durgapal P, Bal CS.68Ga-DOTA-NOC PET and Peptide Receptor Radionuclide Therapy in Management of Bilateral Ovarian Metastases from Gastrointestinal Carcinoid.Jpn J Clin Oncol. 2012 Oct 28. [Epub ahead of print]
Dr. G. Rama Mohan Reddy is a highly accomplished Nuclear Medicine specialist with over 15 years of experience in advanced molecular imaging and targeted radionuclide therapy. Trained at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, he has been extensively involved in high-volume oncologic imaging, thyroid oncology, theranostics, and PET-CT diagnostics across leading tertiary cancer centres.
His expertise spans comprehensive PET-CT imaging for oncology, neurology, cardiology, and endocrine disorders, along with advanced radionuclide therapies for thyroid cancer, neuroendocrine tumors, prostate cancer, and bone metastases. With hands-on experience of over 50,000 PET-CT scans and extensive exposure to cutting-edge GE and Siemens systems, Dr. Reddy has played a key role in integrating molecular imaging into multidisciplinary cancer management.
He is also deeply engaged in academic research, contributing to multiple indexed international publications and abstracts, thereby advancing evidence-based nuclear medicine practice in India.
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R.18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population. Nucl Med Commun. 2012 Sep;33(9):960-6.
- Shamim SA, Kumar R, Halanaik D, Shandal V, Reddy RM, Bal CS, Malhotra A. Detection of recurrent disease in colorectal cancer. Nucl Med Commun 2010 Jun; 31(6);590-6.
- Santra A, Kumar R, Reddy R, Halanaik D, Kumar R, Bal CS, Malhotra A.FDG PET –CT in the management of primary breast lymphoma, Clin Nucl Med. 2009 Dec;34(12):848-53.
- Sharma P, Kumar R, Singh H, Jeph S, Patnecha M, Reddy RM, Naswa N, Bal C, Malhotra A. Imaging thrombus in cancer patients with FDG PET-CT. Jpn J Radiol. 2012 Feb;30(2):95-104. Epub 2011 Dec 22.
- Sharma P, Dhull VS, Reddy RM, Bal C, Thulkar S, Malhotra A, Kumar R. Hybrid SPECT-CT for characterizing isolated vertebral lesions observed by bone scintigraphy: comparison with planar scintigraphy, SPECT, and CT. Diagn Interv Radiol. 2012 Aug 3. doi: 10.4261/1305-3825.DIR.5790-12.1. [Epub ahead of print]
- Sharma JB, Karmakar D, Kumar R, Shamim SA, Kumar S, Singh N, Roy KK, Reddy RM Comparison of PET/CT with other imaging modalities in women with genital tuberculosis. Int J Gynaecol Obstet. 2012 Aug;118(2):123-8. Epub 2012 May 30
- Sharma P, Dhull VS, Jeph S, Reddy RM, Singh H, Naswa N, Bal C, Kumar R. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG? Comparison with planar scintigraphy and SPECT in pheochromocytoma. Clin Nucl Med. (In Press).
- Naswa N, Sharma P, Gupta SK, Karunanithi S, Reddy RM, Patnecha M, Lata S, Kumar R, Malhotra A, Bal C. Dual tracer functional imaging of Gastroenteropancreatic Neuroendocrine tumors using 18F-FDG PET-CT and 68Ga-DOTANOC PET-CT: Competitive or Complimentary? Clin Nucl Med. (In Press).
- Damle N, Bal C, Reddy R, Kumar P, Vireka D. Short term outcome of empirical low fixed dose radioiodine therapy in diffuse toxic goiter. Hormones- International Journal of Endocrinology and Metabolism. (In Press)
- Chawla M, Reddy R, Kumar R, Das CJ, Agarwala S, Tiwari AM, Malhotra A, Kumar R. Role of FDG PET?CT in detection of meningeal metastasis in neuroblastoma. Pediatr Surg Int.2009 Feb;25(2):211-5
- Singh H, Sharma P, Suman K C S, Reddy RM, Bal C, Malhotra A, Kumar R. Postorchiectomy intrascrotal hematoma mimicking local recurrence on 18F-FDG PET/CT: a diagnostic dilemma. Clin Nucl Med. 2012 May;37(5):e102-3.
- Singh H, Sharma P, Reddy RM, Bal C, Malhotra A, Kumar R. Sister Mary Joseph's Nodule in endometrial carcinoma: Detection with FDG PET-CT. Clin Nucl Med (In Press)
- Singla S, Gupta S, Reddy RM, Durgapal P, Bal CS.68Ga-DOTA-NOC PET and Peptide Receptor Radionuclide Therapy in Management of Bilateral Ovarian Metastases from Gastrointestinal Carcinoid.Jpn J Clin Oncol. 2012 Oct 28. [Epub ahead of print]
Dr. G. Rama Mohan Reddy is a highly accomplished Nuclear Medicine specialist with over 15 years of experience in advanced molecular imaging and targeted radionuclide therapy. Trained at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, he has been extensively involved in high-volume oncologic imaging, thyroid oncology, theranostics, and PET-CT diagnostics across leading tertiary cancer centres.
His expertise spans comprehensive PET-CT imaging for oncology, neurology, cardiology, and endocrine disorders, along with advanced radionuclide therapies for thyroid cancer, neuroendocrine tumors, prostate cancer, and bone metastases. With hands-on experience of over 50,000 PET-CT scans and extensive exposure to cutting-edge GE and Siemens systems, Dr. Reddy has played a key role in integrating molecular imaging into multidisciplinary cancer management.
He is also deeply engaged in academic research, contributing to multiple indexed international publications and abstracts, thereby advancing evidence-based nuclear medicine practice in India.
- PET-CT Imaging (FDG, PSMA, DOTANOC, DOPA, NaF)
- Thyroid Cancer & Hyperthyroidism Management (131I Therapy)
- Theranostics (177Lu Therapy for NET & Prostate Cancer)
- Nuclear Cardiology & Myocardial Perfusion Imaging
- Radiosynovectomy for Chronic Arthritis
- Bone Pain Palliation Using 153Samarium & 89Strontium
- English
- Kannada
- Telugu
- Hindi
Talks & Publications
Overview
Field of Expertise
Languages Spoken
FAQ's
Patients visit Dr. G. Rama Mohan Reddy, a leading Lead Consultant - Nuclear Medicine at Manipal Hospitals Yelahanka - Bengaluru, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. G. Rama Mohan Reddy is a trusted choice for exceptional medical support.
Dr. G. Rama Mohan Reddy Specialises in:
- PET-CT Imaging (FDG, PSMA, DOTANOC, DOPA, NaF)
- Thyroid Cancer & Hyperthyroidism Management (131I Therapy)
- Theranostics (177Lu Therapy for NET & Prostate Cancer)
- Nuclear Cardiology & Myocardial Perfusion Imaging
- Radiosynovectomy for Chronic Arthritis
- Bone Pain Palliation Using 153Samarium & 89Strontium
To book an appointment with Dr. G. Rama Mohan Reddy at Manipal Hospitals Yelahanka - Bengaluru, please call 1800 102 5555. Our dedicated team will assist you in scheduling a convenient time for your consultation.
Dr. G. Rama Mohan Reddy has extensive experience and qualifications in Medical Oncology at Manipal Hospitals Yelahanka - Bengaluru. With expertise spanning MBBS . MD (Nuclear Medicine) . Certified Radiological Safety Officer, bringing a wealth of knowledge and skill to their practice, ensuring top-notch patient care. Dr. G. Rama Mohan Reddy has also published numerous articles and publications in the field of Medical Oncology.
For your initial appointment with Dr. G. Rama Mohan Reddy, please bring any relevant medical records, including previous imaging scans, laboratory results, and medication lists. It's important to provide a detailed medical history and any pertinent information about your condition. If you have insurance, please bring your insurance card and any necessary referral documents. This will help facilitate a comprehensive evaluation and discussion during your appointment.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
You’re on Our Indian Website
Visit the Global site for International patient services
